Search Results - "Radner, F"

Refine Results
  1. 1
  2. 2

    Time to onset of improvements in Quality of Life from Temperature-controlled Laminar Airflow (TLA) in severe allergic asthma by Bjermer, L., Eriksson, G., Radner, F., Peterson, Stefan, Warner, J.O.

    Published in Respiratory medicine (01-02-2019)
    “…Allergen avoidance is important in allergic asthma management. Nocturnal treatment with Temperature-controlled Laminar Airflow (TLA; Airsonett®) has been shown…”
    Get full text
    Journal Article
  3. 3

    Monoglyceride lipase deficiency causes desensitization of intestinal cannabinoid receptor type 1 and increased colonic μ‐opioid receptor sensitivity by Taschler, U, Eichmann, T O, Radner, F P W, Grabner, G F, Wolinski, H, Storr, M, Lass, A, Schicho, R, Zimmermann, R

    Published in British journal of pharmacology (01-09-2015)
    “…Background and Purpose Monoglyceride lipase (MGL) degrades 2‐arachidonoyl glycerol (2‐AG), an endogenous agonist of cannabinoid receptors (CB1/2). Because the…”
    Get full text
    Journal Article
  4. 4

    Temperature-controlled Laminar Airflow (TLA) in symptomatic severe asthma – a post hoc analysis of severe exacerbations, quality of life and health economics by Chauhan, A. J, Eriksson, G, Storrar, W, Brown, T, Peterson, S, Radner, F, D'Cruz, L. G, Miller, P, Bjermer, L

    Published in BMC pulmonary medicine (09-11-2022)
    “…Abstract Purpose Uncontrolled severe asthma constitutes a major economic burden to society. Add-ons to standard inhaled treatments include inexpensive oral…”
    Get full text
    Journal Article
  5. 5

    Long-acting β-agonists : a review of formoterol safety data from asthma clinical trials by SEARS, M. R, OTTOSSON, A, RADNER, F, SUISSA, S

    Published in The European respiratory journal (2009)
    “…The safety of long-acting beta(2)-agonist (LABA) treatment in asthma has been questioned following reported increased respiratory deaths when salmeterol was…”
    Get full text
    Journal Article
  6. 6

    Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroids by O'Byrne, P.M, Rennard, S, Gerstein, H, Radner, F, Peterson, S, Lindberg, B, Carlsson, L.-G, Sin, D.D

    Published in Respiratory medicine (01-11-2012)
    “…Summary Background A recent case-controlled study reported an increased risk of diabetes mellitus in patients treated with inhaled corticosteroids for asthma…”
    Get full text
    Journal Article
  7. 7

    Reduced Variability of Endurance Time in New Protocols for Exercise Tests in COPD [Corrigendum] by Tufvesson, Ellen, Radner, Finn, Papapostolou, Georgia, Jarenbäck, Linnea, Jönsson, Saga, Nihlén, Ulf, Ankerst, Jaro, Tunsäter, Alf, Peterson, Stefan, Bjermer, Leif, Eriksson, Göran

    “…Tufvesson E, Radner F, Papapostolou G, et al. Int J Chron Obstruct Pulmon Dis. 2020;15:3003–3012. Page 3004, left column, line 2 from the bottom, the sentence…”
    Get full text
    Journal Article
  8. 8

    Effect of nocturnal Temperature-controlled Laminar Airflow on the reduction of severe exacerbations in patients with severe allergic asthma: a meta-analysis by Chauhan, A. J., Brown, T. P., Storrar, W., Bjermer, L., Eriksson, G., Radner, F., Peterson, S., Warner, J. O.

    Published in European clinical respiratory journal (01-01-2021)
    “…Background: Allergen avoidance is important in allergic asthma management. Nocturnal treatment with Temperature-controlled Laminar Airflow (TLA) has been shown…”
    Get full text
    Journal Article
  9. 9

    Reduced Variability of Endurance Time in New Protocols for Exercise Tests in COPD by Tufvesson, Ellen, Radner, Finn, Papapostolou, Georgia, Jarenback, Linnea, Jonsson, Saga, Nihlen, Ulf, Ankerst, Jaro, Tunsater, Alf, Peterson, Stefan, Bjermer, Leif, Eriksson, Goran

    “…Purpose: For exercise testing of COPD patients, a standard endurance test (ET) with constant workload is recommended. The test suffers from large…”
    Get full text
    Journal Article
  10. 10

    Safety of formoterol in children and adolescents: experience from asthma clinical trials by Price, J F, Radner, F, Lenney, W, Lindberg, B

    Published in Archives of disease in childhood (01-12-2010)
    “…Background The safety of long-acting β2 agonist (LABA) therapy in asthma remains controversial but no large scale analyses have been published of LABA safety…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Safety of formoterol in asthma clinical trials: an update by SEARS, Malcolm R, RADNER, Finn

    Published in The European respiratory journal (01-01-2014)
    “…Use of long-acting β-agonists (LABAs) in asthma remains controversial, and large safety trials are in progress. We have previously reported safety outcomes…”
    Get full text
    Journal Article
  15. 15

    Budesonide and the risk of pneumonia: a meta-analysis of individual patient data by Sin, Don D, Dr, Tashkin, Donald, Prof, Zhang, Xuekui, MSc, Radner, Finn, PhD, Sjöbring, Ulf, MD, Thorén, Anders, MD, Calverley, Peter MA, Prof, Rennard, Stephen I, Prof

    Published in The Lancet (British edition) (29-08-2009)
    “…Summary Background Concern is continuing about increased risk of pneumonia in patients with chronic obstructive pulmonary disease (COPD) who use inhaled…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Safety of budesonide/formoterol maintenance and reliever therapy in asthma trials by Sears, Malcolm R, Radner, Finn

    Published in Respiratory medicine (01-12-2009)
    “…Summary Background The safety of long-acting β2 -agonists (LABAs) in asthma is debated. This study examined the safety of the inhaled corticosteroid (ICS)/LABA…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Safety of formoterol in patients with asthma: Combined analysis of data from double-blind, randomized controlled trials by Nelson, Harold, MD, Bonuccelli, Catherine, MD, Radner, Finn, PhD, Ottosson, Anders, MD, PhD, Carroll, Kevin J., MSc, BSc, Andersson, Tomas L.G., MD, PhD, LaForce, Craig, MD

    Published in Journal of allergy and clinical immunology (01-02-2010)
    “…Background Concerns exist that regular long-acting β2 -adrenergic agonist (LABA) therapy may increase the risk of serious asthma-related events. Objective To…”
    Get full text
    Journal Article
  20. 20

    Outcome of pregnancy in a randomized controlled study of patients with asthma exposed to budesonide by Silverman, Michael, Sheffer, Albert, Diaz, Patricia V, Lindmark, Bertil, Radner, Finn, Broddene, Maria, de Verdier, Maria Gerhardsson, Pedersen, Søren, Pauwels, Romain A

    Published in Annals of allergy, asthma, & immunology (01-12-2005)
    “…Budesonide is the only inhaled corticosteroid to be given a category B pregnancy rating by the US Food and Drug Administration, based on observational data…”
    Get more information
    Journal Article